The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Natural killer cell-mediated immunosurveillance of human cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Self-citationHLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Self-citationNatural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.014 · Cited by 1,209
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
Kiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,059
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J. H., Zanotelli, V. R. T., Silina, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,004
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Romee, R., Rosario, M., Berrien-Elliott, M. M., Wagner, J. A., Jewell, B. A., Schappe, T., Leong, J. W., Abdel-Latif, S., Schneider, S. E., Willey, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2341 · Cited by 942
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
Self-citationImprint of human cytomegalovirus infection on the NK cell receptor repertoire
Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N., & López-Botet, M. (2004) · Blood · doi:10.1182/blood-2004-05-2058 · Cited by 865
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992) · Nature · doi:10.1038/358066a0 · Cited by 797
Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H., Chiang, S. C. C., Foley, B., Mattsson, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.008 · Cited by 787
Self-citationLopez-Vergès, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J., Nixon, D. F., & Lanier, L. L. (2010) · Blood · doi:10.1182/blood-2010-04-282301 · Cited by 752
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Self-citationBjörkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Björklund, A. T., Flodström-Tullberg, M., Michaëlsson, J., Rottenberg, M. E., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281675 · Cited by 734
Self-citationValiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
Spinner, M. A., Sanchez, L. A., Hsu, A. P., Shaw, P. A., Zerbe, C. S., Calvo, K. R., Arthur, D. C., Gu, W., Gould, C. M., Brewer, C. C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515528 · Cited by 712
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Viel, S., Marçais, A., Guimaraes, F. S.-F., Loftus, R., Rabilloud, J., Grau, M., Degouve, S., Djebali, S., Sanlaville, A., Charrier, E., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad1884 · Cited by 672
Activation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650
Self-citationRubnitz, J. E., Inaba, H., Ribeiro, R. C., Pounds, S., Rooney, B., Bell, T., Pui, C.-H., & Leung, W. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4590 · Cited by 649
Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding
Salih, H. R., Rammensee, H.-G., & Steinle, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4098 · Cited by 643
DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes
Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)70060-4 · Cited by 641
Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S., Lanier, L. L., Weisdorf, D., & Miller, J. S. (2012) · Blood · doi:10.1182/blood-2011-10-386995 · Cited by 630
Cerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Perforin-mediated target-cell death and immune homeostasis
Voskoboinik, I., Smyth, M. J., & Trapani, J. A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1983 · Cited by 592
Prognostic value of intratumoral natural killer cells in gastric carcinoma
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<577::aid-cncr13>3.0.co;2-v · Cited by 586
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E., Mortier, E., Jacques, Y., Spits, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082013 · Cited by 577
Lee, J., Zhang, T., Hwang, I., Kim, A., Nitschke, L., Kim, M., Scott, J. M., Kamimura, Y., Lanier, L. L., & Kim, S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.013 · Cited by 552
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
Self-citationMoretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., & Moretta, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.597 · Cited by 534
Béziat, V., Liu, L. L., Malmberg, J.-A., Ivarsson, M. A., Sohlberg, E., Björklund, A. T., Retière, C., Sverremark-Ekström, E., Traherne, J., Ljungman, P., et al. (2013) · Blood · doi:10.1182/blood-2012-10-459545 · Cited by 512
Self-citationNatural killer cell deficiency
Orange, J. S. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.020 · Cited by 504
Villegas, F. R., Coca, S., Villarrubia, V. G., Jiménez, R., Chillón, M. J., Jareño, J., Zuil, M., & Callol, L. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00292-6 · Cited by 467
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A., & López-Botet, M. (2006) · Blood · doi:10.1182/blood-2005-09-3682 · Cited by 449
Emerging insights into natural killer cells in human peripheral tissues
Björkström, N. K., Ljunggren, H.-G., & Michaëlsson, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.34 · Cited by 449
Self-citationMolecular mechanisms of biogenesis and exocytosis of cytotoxic granules
de Saint Basile, G., Ménasché, G., & Fischer, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2803 · Cited by 446
Wu, L., Adams, M., Carter, T., Chen, R., Muller, G., Stirling, D., Schafer, P., & Bartlett, J. B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4405 · Cited by 440
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
Bachanova, V., Cooley, S., Defor, T. E., Verneris, M. R., Zhang, B., McKenna, D. H., Curtsinger, J., Panoskaltsis-Mortari, A., Lewis, D., Hippen, K., et al. (2014) · Blood · doi:10.1182/blood-2013-10-532531 · Cited by 435
Effect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 394
Fauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., & Costello, R. T. (2007) · Blood · doi:10.1182/blood-2005-08-027979 · Cited by 380
Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Wendel, M., Galani, I. E., Suri-Payer, E., & Cerwenka, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1440 · Cited by 378
Pende, D., Spaggiari, G. M., Marcenaro, S., Martini, S., Rivera, P., Capobianco, A., Falco, M., Lanino, E., Pierri, I., Zambello, R., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3548 · Cited by 374
Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J., Vivier, É., Anderson, P., & Kiessling, R. W. (1993) · PubMed · Cited by 339
Carbone, E. (2005) · Blood · doi:10.1182/blood-2004-04-1422 · Cited by 333
El-Sherbiny, Y. M., Meade, J. L., Holmes, T. D., McGonagle, D., Mackie, S. L., Morgan, A. W., Cook, G., Feyler, S., Richards, S. J., Davies, F. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4230 · Cited by 321
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells
Juelke, K., Killig, M., Luetke-Eversloh, M., Parente, E., Gruen, J., Morandi, B., Ferlazzo, G., Thiel, A., Schmitt-Knosalla, I., & Romagnani, C. (2010) · Blood · doi:10.1182/blood-2009-11-253286 · Cited by 286
Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B., Theodorou, I., Martinot, M., Debré, P., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141826 · Cited by 284
Self-citationCarlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., & Malmberg, K.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901226 · Cited by 283
Self-citationKobayashi, H., Dubois, S., Sato, N., Sabzevari, H., Sakai, Y., Waldmann, T. A., & Tagaya, Y. (2005) · Blood · doi:10.1182/blood-2003-12-4187 · Cited by 275
Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells
Castriconi, R., Dondero, A., Corrias, M. V., Lanino, E., Pende, D., Moretta, L., Bottino, C., & Moretta, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2682 · Cited by 259
Della Chiesa, M., Falco, M., Podestà, M., Locatelli, F., Moretta, L., Frassoni, F., & Moretta, A. (2012) · Blood · doi:10.1182/blood-2011-08-372003 · Cited by 254
Santourlidis, S., Trompeter, H.-I., Weinhold, S., Eisermann, B., Meyer, K. L., Wernet, P., & Uhrberg, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4253 · Cited by 253
Ligands for natural killer cell receptors: redundancy or specificity
Cerwenka, A., & Lanier, L. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810113.x · Cited by 248
HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?
Rouas-Freiss, N., Moreau, P., Ferrone, S., & Carosella, E. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0097 · Cited by 247
Genetic Control of Human NK Cell Repertoire
Shilling, H. G., Young, N., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Tyan, D., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.239 · Cited by 245
Hilpert, J., Grosse-Hovest, L., Grünebach, F., Buechele, C., Nuebling, T., Raum, T., Steinle, A., & Salih, H. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200796 · Cited by 238
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Childs, R. W., & Carlsten, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4506 · Cited by 236
Self-citationYu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I.-K., Liu, S., McClory, S., Marcucci, G., Trotta, R., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215491 · Cited by 235
Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234
Self-citationAntibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
Ochoa, M. C., Minute, L., Rodriguez, I., Garasa, S., Perez‐Ruiz, E., Inogés, S., Melero, I., & Berraondo, P. (2017) · Immunology & Cell Biology · doi:10.1038/icb.2017.6 · Cited by 230
Carrega, P., Bonaccorsi, I., Di Carlo, E., Morandi, B., Paul, P., Rizzello, V., Cipollone, G., Navarra, G., Mingari, M. C., Moretta, L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301889 · Cited by 225
Mlecnik, B., Bindea, G., Angell, H. K., Sasso, M. S., Obenauf, A. C., Fredriksen, T., Lafontaine, L., Bilocq, A. M., Kirilovsky, A., Tosolini, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007240 · Cited by 223
Diermayr, S., Himmelreich, H., Durovic, B., Mathys-Schneeberger, A., Siegler, U., Langenkamp, U., Hofsteenge, J., Gratwohl, A., Tichelli, A., Paluszewska, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-101311 · Cited by 220
Lai, P., Rabinowich, H., Crowley‐Nowick, P. A., Bell, M. C., Mantovani, G., & Whiteside, T. L. (1996) · PubMed · Cited by 218
NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
Béziat, V., Descours, B., Parizot, C., Debré, P., & Vieillard, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011966 · Cited by 217
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+T lymphocytes
Gooden, M., Lampen, M., Jordanova, E. S., Leffers, N., Trimbos, J. B., van der Burg, S. H., Nijman, H., & van Hall, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100354108 · Cited by 215
Tesi, B., Davidsson, J., Voss, M., Rahikkala, E., Holmes, T. D., Chiang, S. C. C., Komulainen-Ebrahim, J., Gorcenco, S., Rundberg Nilsson, A., Ripperger, T., et al. (2017) · Blood · doi:10.1182/blood-2016-10-743302 · Cited by 207
Self-citationSarhan, D., Cichocki, F., Zhang, B., Yingst, A., Spellman, S. R., Cooley, S., Verneris, M. R., Blazar, B. R., & Miller, J. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0839 · Cited by 200
Alici, E., Sutlu, T., Björkstrand, B., Gilljam, M., Stellan, B., Nahi, H., Quezada, H. C., Gahrton, G., Ljunggren, H.-G., & Dilber, M. S. (2008) · Blood · doi:10.1182/blood-2007-09-110312 · Cited by 197
Self-citationShi, J., Tricot, G., Szmania, S., Rosen, N., Garg, T. K., Malaviarachchi, P. A., Moreno, A., DuPont, B., Hsu, K. C., Baxter‐Lowe, L. A., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07340.x · Cited by 194
A proportion of patients with lymphoma may harbor mutations of the perforin gene
Clementi, R. (2005) · Blood · doi:10.1182/blood-2004-04-1477 · Cited by 188
Targeting NK-cell checkpoints for cancer immunotherapy
Muntasell, A., Ochoa, M. C., Cordeiro, L., Berraondo, P., López-Díaz de Cerio, A., Cabo, M., López-Botet, M., & Melero, I. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.01.003 · Cited by 182
Malmberg, K.-J., Levitsky, V., Norell, H., Matos, C. T. D., Carlsten, M., Schedvins, K., Rabbani, H., Moretta, A., Söderström, K., Levitskaya, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15564 · Cited by 180
Self-citationNK cell recognition of non-classical HLA class I molecules
López-Botet, Llano, M., Navarro, F., & Bellon, T. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0213 · Cited by 179
Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells
Screpanti, V., Wallin, R. P. A., Grandien, A., & Ljunggren, H.-G. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.033 · Cited by 172
Self-citationAllogeneic hematopoietic transplantation and natural killer cell recognition of missing self
Ruggeri, L., Aversa, F., Martelli, M. F., & Velardi, A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00455.x · Cited by 172
Pagel, J., Beutel, K., Lehmberg, K., Koch, F., Maul-Pavicic, A., Rohlfs, A.-K., Al-Jefri, A., Beier, R., Bomme Ousager, L., Ehlert, K., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398958 · Cited by 167
Chiang, S. C. C., Theorell, J., Entesarian, M., Meeths, M., Mastafa, M., Al–Herz, W., Frisk, P., Gilmour, K. C., Ifversen, M., Langenskiöld, C., et al. (2013) · Blood · doi:10.1182/blood-2012-07-442558 · Cited by 161
Self-citationRole of Distinct Natural Killer Cell Subsets in Anticancer Response
Stabile, H., Fionda, C., Gismondi, A., & Santoni, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00293 · Cited by 149
Ali, T. H., Pisanti, S., Ciaglia, E., Mortarini, R., Anichini, A., Garofalo, C., Tallerico, R., Santinami, M., Gulletta, E., Ietto, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6639 · Cited by 145
Curti, A., Ruggeri, L., Parisi, S., Bontadini, A., Dan, E., Motta, M. R., Rizzi, S., Trabanelli, S., Očadlíková, D., Lecciso, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1604 · Cited by 142
Yvon, E. S., Burga, R. A., Powell, A. B., Cruz, C. C., Fernandes, R., Barese, C. N., Nguyen, T., Abdelbaki, M. S., & Bollard, C. M. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2016.12.005 · Cited by 135
NK cells gain higher IFN ‐γ competence during terminal differentiation
Luetke-Eversloh, M. V., Cicek, B. B., Siracusa, F., Thom, J. T., Hamann, A., Frischbutter, S., Baumgrass, R., Chang, H., Thiel, A., Dong, J., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344072 · Cited by 129
Carlsten, M., Baumann, B. C., Simonsson, M., Jädersten, M., Forsblom, A., Hammarstedt, C., Bryceson, Y. T., Ljunggren, H., Hellström‐Lindberg, E., & Malmberg, K. (2010) · Leukemia · doi:10.1038/leu.2010.149 · Cited by 126
Self-citationAnti‐myeloma activity of natural killer lymphocytes
Frohn, C., Höppner, M., Schlenke, P., Kirchner, H., Koritke, P., & Luhm, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03879.x · Cited by 124
HLA expression in uveal melanoma: there is no rule without some exception
Jager, M. J., Hurks, H. M. H., Levitskaya, J., & Kiessling, R. W. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00389-0 · Cited by 122
Bachanová, V., & Miller, J. S. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014011091 · Cited by 117
IL-10 stimulatory effects on human NK cells explored by gene profile analysis
D, S. M. M., Panelli, M. C., Wang, E., Rossi, C. R., Pilati, P., Nitti, D., Lise, M., & Marincola, F. M. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364135 · Cited by 113
NK Cells and Cancer Immunoediting
Guillerey, C., & Smyth, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_446 · Cited by 110
Rudd, E., Ericson, K. G., Zheng, C., Uysal, Z., Özkan, A., Gürgey, A., Fadeel, B., Nordenskjöld, M., & Henter, J. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035253 · Cited by 109
The unconventional expression of IL‐15 and its role in NK cell homeostasis
Huntington, N. D. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.1 · Cited by 105
Human Leukocyte Antigen–G and Cancer Immunoediting
Urosevic, M., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2704 · Cited by 101
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
Luna, J. I., Grossenbacher, S. K., Murphy, W. J., & Canter, R. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1271874 · Cited by 100
Godal, R., Bachanová, V., Gleason, M., McCullar, V., Yun, G. H., Cooley, S., Verneris, M. R., McGlave, P. B., & Miller, J. S. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.01.019 · Cited by 97
Epigenetic regulation of NK cell differentiation and effector functions
Cichocki, F. M., Miller, J. S., Anderson, S. K., & Bryceson, Y. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00055 · Cited by 93
Self-citationGarrido, F., Perea, F., Bernal, M., Sánchez‐Palencia, A., Aptsiauri, N., & Ruiz‐Cabello, F. (2017) · Vaccines · doi:10.3390/vaccines5010007 · Cited by 89
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles
Sandberg, R., & Ernberg, I. (2005) · Genome Biology · doi:10.1186/gb-2005-6-8-r65 · Cited by 84
Newtonian cell interactions shape natural killer cell education
Goodridge, J. P., Önfelt, B., & Malmberg, K. (2015) · Immunological Reviews · doi:10.1111/imr.12325 · Cited by 84
Self-citationEx Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
Liu, L. L., Béziat, V., Oei, V. Y. S., Pfefferle, A., Schaffer, M., Lehmann, S., Hellström‐Lindberg, E., Söderhäll, S., Heyman, M. M., Grandér, D., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0296 · Cited by 83
Self-citationAdaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells
Schlums, H., Jung, M., Han, H., Theorell, J., Bigley, V., Chiang, S. C. C., Allan, D., Davidson-Moncada, J. K., Dickinson, R. E., Holmes, T. D., et al. (2017) · Blood · doi:10.1182/blood-2016-08-734236 · Cited by 80
Self-citationEscape from immune- and nonimmune-mediated tumor surveillance.
Malmberg, K., & Ljunggren, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.007 · Cited by 76
Self-citationBoieri, M., Ulvmoen, A., Sudworth, A., Lendrem, C., Collin, M. P., Dickinson, A. M., Kveberg, L., & Inngjerdingen, M. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1274478 · Cited by 76
Geller, M. A., Knorr, D. A., Hermanson, D., Pribyl, L. J., Bendzick, L. E., McCullar, V., Miller, J. S., & Kaufman, D. S. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.05.022 · Cited by 73
NK cell development and function--plasticity and redundancy unleashed.
Cichocki, F., Sitnicka, E., & Bryceson, Y. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.003 · Cited by 69
Self-citationClinical characteristics and outcomes of chédiak–Higashi syndrome: A nationwide survey of Japan
Nagai, K., Ochi, F., Terui, K., Maeda, M., Ohga, S., Kanegane, H., Kitoh, T., Kogawa, K., Suzuki, N., Ohta, S., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24637 · Cited by 66
Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity
Strayer, D. R., Carter, W. A., & Brodsky, I. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01806249 · Cited by 66
Re, F., Staudacher, C., Zamai, L., Vecchio, V., & Bregni, M. (2006) · Cancer · doi:10.1002/cncr.22002 · Cited by 65
Natural killer cell immunotherapy to target stem-like tumor cells
Grossenbacher, S. K., Canter, R. J., & Murphy, W. J. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0124-2 · Cited by 53
Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab
Taylor, R. J., Saloura, V., Jain, A. K., Goloubeva, O. G., Wong, S. J., Kronsberg, S. S., Nagilla, M., Silpino, L., de Souza, J., Seiwert, T. Y., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0188 · Cited by 50
Pascal, V., Stulberg, M., & Anderson, S. K. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00452.x · Cited by 49
Shafer, D. A., Smith, M. R., Borghaei, H., Millenson, M. M., Li, T., Litwin, S., Anad, R., & Al‐Saleem, T. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.038 · Cited by 48
Corat, M. A. F., Schlums, H., Wu, C., Theorell, J., Espinoza, D. A., Sellers, S. E., Townsley, D. M., Young, N. S., Bryceson, Y. T., Dunbar, C. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-734285 · Cited by 46
Self-citationHarnessing adaptive natural killer cells in cancer immunotherapy
Liu, L. L., Pfefferle, A., Oei, V. Y. S., Björklund, A. T., Béziat, V., Goodridge, J. P., & Malmberg, K. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.001 · Cited by 42
Self-citationPathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity
Meeths, M., Chiang, S. C. C., Löfstedt, A., Müller, M., Tesi, B., Henter, J., & Bryceson, Y. T. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.014 · Cited by 40
Self-citationDevelopment of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations
Machaczka, M., Klimkowska, M., Chiang, S. C. C., Meeths, M., Muller, M.-L., Gustafsson, B. M., Henter, J., & Bryceson, Y. T. (2012) · Haematologica · doi:10.3324/haematol.2012.073098 · Cited by 38
Self-citationFamilial cancer, emotional distress, and low natural cytotoxic activity in healthy women
Bovbjerg, D. H., & Valdimarsdottir, H. B. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058659 · Cited by 37
Löfstedt, A., Chiang, S. C. C., Onelöv, E., Bryceson, Y. T., Meeths, M., & Henter, J. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00223-9 · Cited by 36
Self-citationNatural killer cell biology illuminated by primary immunodeficiency syndromes in humans
Voß, M., & Bryceson, Y. T. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.11.004 · Cited by 33
Self-citationNatural killer cell‐mediated lysis of freshly isolated human tumor cells
Carlsten, M., Malmberg, K., & Ljunggren, H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24082 · Cited by 31
Self-citationFeuchtinger, T. F., Pfeiffer, M. M., Pfäffle, A., Teltschik, H.-M., Wernet, D., Schumm, M., Lotfi, R., Handgretinger, R., & Lang, P. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.398 · Cited by 28
Tolerant and diverse natural killer cell repertoires in the absence of selection
Andersson, S., Malmberg, J.-A., & Malmberg, K. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.030 · Cited by 17
Self-citation
Cited by
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Hsu, J., Hodgins, J. J., Marathe, M., Nicolai, C. J., Bourgeois-Daigneault, M.-C., Trevino, T. N., Azimi, C. S., Scheer, A. K., Randolph, H. E., Thompson, T. W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99317 · Cited by 817
Natural killer cells in antitumour adoptive cell immunotherapy
Laskowski, T. J., Biederstädt, A., & Rezvani, K. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00491-0 · Cited by 773
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
Metadata
- Authors
- Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 31
- Pages
- 20-29
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2753621408
- Cited by
- 299
- References
- 147
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.